McAndrew RP,Wang Y,Mohsen AW,e t al. Structural basis for substrate fatty acyl chain specificity- crystal structure of human very- long- chain acyl- CoA dehydrogenase[J].Biol Chem,2008,283(14):9435-9443.
[2]
Coughlin CR,Ficicioglu C.Genotype-phenotype correlations; sudden death in an infant with very-long-chain acyl-CoA dehydrogenase[J].Inherit Metab Dis,2010[Epub ahead of print].
Lund AM,Skovby F,Vestergaard H,et al.Clinical and biochemical monitoring of patients with fatty acid oxidation disorders[J].J Inherit Metab Dis,2010,33:495-500.
[5]
Nada MA,Rhead WJ,Sprecher RH,et al.Evidence for intermediate channeling in mitochondrial oxidation[J]. Biol Chem,1995,270(2):530-535.
[6]
Garg U,Dasouki M.Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry:Clinical and laboratory aspects[J].Clin Biochem,2006,39(4):315-332.
[7]
Vockley J.Glutaric aciduria type 2 and newborn screening:Commentary[J].Molecular Genetics and Metabolism,2008,93(7):5-6.
Spiekerkoetter U,LindnerM,Santer R,et al. Management and outcome in 75 individuals with long- chain fatty acid oxidation defects:Results from a work shop[J]. Inherit Metab Dis,2009,32(4):488- 497.
Tucci S,Primassin S,Spiekerkoetter U.Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficiency mice[J].FEBS J,2010,277(22):4699-4708.
